ATRI - Atrion Corp. Long-Term Debt Volume

Graphic logo of Atrion Corporation Inc. (ATRI)

The price visualization for Atrion Corporation (ATRI), which assists in the basic asset valuation, is based on the development of high-precision fluid delivery systems that integrate into B2B partners' projects, creating high switching costs. The indicator stands at 0.00. Atrion Corporation (ATRI) resists the expansion of industry behemoths by fighting for intellectual property. Meanwhile, the company has achieved cost optimization by outsourcing the casting of simple parts to contractors, focusing capital on final assembly.

ATRI Atrion Corporation Company Long-Term Debts (07/04/2022 - 08/31/2024)

Atrion Corp - analytical breakdowns and key metrics (ATRI)

- share price and expert price forecast:
Share Price atrioncorp.com|ATRI - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Atrion|ATRI - Enterprise Value
- balance sheet equity data:
Accounting Value per Share Atrion|ATRI - Book Capitalization|Market Capitalization to Book Value Ratio atrioncorp.com|ATRI - Aggregate Company Assets
- business debt structure and liquidity details:
Debt to Equity Atrion Corporation|ATRI - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Atrion Corporation Inc.|ATRI - Company Aggregate Debts|Debts to Net Assets Atrion|ATRI - Company Long-Term Debt|Company Short-Term Indebtedness Atrion|Interim Coverage Ratio atrioncorp.com
- earnings and multiples data:
ATRI - Net Income
Summary company analytics:ATRI atrioncorp.com
Manufactured products of Atrion Corporation Inc.

Atrion Corporation (ATRI) maintains a strong position within the defensive medical consumables segment. By analyzing the changes in the issuer's long-term liabilities, one can evaluate the company's borrowing strategy. This metric aggregates all credit obligations with a maturity of more than one year, reflecting the long-term financial burden. For a non-cyclical business in cardiology, such debts are typically serviced by a stable cash flow. Investors should consider this volume of loans in conjunction with total equity.

Competitors of Atrion Corporation (ATRI)

ISRG: Company Long-Term Indebtedness|Danaher - Company Long-Term Debts|Long-Term Debt Volume BD BDX|STE: Company Long-Term Debts|Company Long-Term Liabilities West Pharma Corp|BAX (Baxter International) - Company Long-Term Debts|Company Long-Term Debts masimo.com|Company Long-Term Debt Stevanato Group (STVN)|Company Long-Term Debt TFX (Teleflex Inc.)|Merit Medical Systems Inc - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings NVST|ICU Medical, Inc. - Company Long-Term Debts|Long-Term Debt Volume dentsplysirona.com XRAY|LeMaitre Vascular (LMAT) - Company Long-Term Debt|Company Long-Term Indebtedness ATRC|Company Long-Term Debt STAAR Surgical Corp|niagenbioscience.com (NAGE) - Long-Term Debt Volume|Company Long-Term Liabilities ZIMV (ZimVie Inc.)|Amount of Long-Term Liabilities ANGO|Company Long-Term Debt Cerus CERS|Company Long-Term Loans and Borrowings TKNO|MGRM: Company Long-Term Liabilities|STSS - Company Long-Term Debts|infusystem.com (INFU) - Company Long-Term Debt|Company Long-Term Liabilities utahmed.com|KRMD (KORU Medical Systems, Inc.) - Company Long-Term Debts|Long-Term Debt Nyxoah SA NYXH|Company Long-Term Debt Microbot Medical Inc (MBOT)|Pro-Dex Inc. - Company Long-Term Indebtedness|Zentek Ltd. - Company Long-Term Liabilities|Amount of Long-Term Liabilities ELUT (elutia.com)|MLSS - Company Long-Term Debt|Long-Term Debt Volume NEXGEL Inc. NXGL|RVP: Company Long-Term Debts|Harvard Bioscience Inc. (HBIO) - Company Long-Term Debts|Company Long-Term Liabilities FEMY|MHUA (Meihua Medical) - Amount of Long-Term Liabilities|Company Long-Term Debt Predictive Oncology (POAI)|CJMB (callanjmb.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debts NURO (NeuroMetrix Corp)